{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:16:43Z","timestamp":1788470203455,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"DOI":"10.1038\/s41430-026-01805-3","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:26:00Z","timestamp":1788467160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dietary one-carbon metabolism nutrients and risk of MASLD progression: a prospective cohort study"],"prefix":"10.1038","author":[{"given":"Lijun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-1844","authenticated-orcid":false,"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-730X","authenticated-orcid":false,"given":"Xiahong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S32\u2013S50.","journal-title":"Clin Mol Hepatol"},{"key":"1805_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35:697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"key":"1805_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","volume":"17","author":"D Ferguson","year":"2021","unstructured":"Ferguson D, Finck BN. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17:484\u201395.","journal-title":"Nat Rev Endocrinol"},{"key":"1805_CR4","doi-asserted-by":"publisher","first-page":"100815","DOI":"10.1016\/j.jhepr.2023.100815","volume":"5","author":"A De Masi","year":"2023","unstructured":"De Masi A, Li XX, Lee D, Jeon J, Wang Q, Baek S, et al. Cyclo(His-Pro): a further step in the management of steatohepatitis. JHEP Rep. 2023;5:100815.","journal-title":"JHEP Rep"},{"key":"1805_CR5","doi-asserted-by":"crossref","unstructured":"Jurek JM, Zablocka-Sowinska K, Clavero Mestres H, Reyes Guti\u00e9rrez L, Camaron J, Auguet T. The impact of dietary interventions on metabolic outcomes in metabolic dysfunction-associated steatotic liver disease (MASLD) and comorbid conditions, including obesity and type 2 diabetes. Nutrients. 2025;17:1257.","DOI":"10.3390\/nu17071257"},{"key":"1805_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/jn\/nxaa032","volume":"150","author":"RP da Silva","year":"2020","unstructured":"da Silva RP, Eudy BJ, Deminice R. One-carbon metabolism in fatty liver disease and fibrosis: one-carbon to rule them all. J Nutr. 2020;150:994\u20131003.","journal-title":"J Nutr"},{"key":"1805_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25:27\u201342.","journal-title":"Cell Metab"},{"key":"1805_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mam.2016.11.007","volume":"54","author":"S Friso","year":"2017","unstructured":"Friso S, Udali S, De Santis D, Choi SW. One-carbon metabolism and epigenetics. Mol Asp Med. 2017;54:28\u201336.","journal-title":"Mol Asp Med"},{"key":"1805_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jimd.12009","volume":"42","author":"DS Froese","year":"2019","unstructured":"Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42:673\u201385.","journal-title":"J Inherit Metab Dis"},{"key":"1805_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","volume":"1821","author":"LK Cole","year":"2012","unstructured":"Cole LK, Vance JE, Vance DE. Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim Biophys Acta. 2012;1821:754\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"1805_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/oby.22667","volume":"28","author":"ZW Lai","year":"2020","unstructured":"Lai ZW, Chen JL, Ding CH, Wong KS, Chen XY, Pu LZ, et al. Association of hepatic global DNA methylation and serum one-carbon metabolites with histological severity in patients with NAFLD. Obes (Silver Spring). 2020;28:197\u2013205.","journal-title":"Obes (Silver Spring)"},{"key":"1805_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/livers2040020","volume":"2","author":"D Fern\u00e1ndez-Ramos","year":"2022","unstructured":"Fern\u00e1ndez-Ramos D, Lopitz-Otsoa F, Millet O, Alonso C, Lu SC, Mato JM. One carbon metabolism and S-adenosylmethionine in non-alcoholic fatty liver disease pathogenesis and subtypes. Livers. 2022;2:243\u201357.","journal-title":"Livers"},{"key":"1805_CR13","doi-asserted-by":"publisher","first-page":"1141156","DOI":"10.3389\/fnut.2023.1141156","volume":"10","author":"BD Yao","year":"2023","unstructured":"Yao BD, Lu XJ, Xu L, Jiang Y. Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011-2018). Front Nutr. 2023;10:1141156.","journal-title":"Front Nutr"},{"key":"1805_CR14","doi-asserted-by":"publisher","first-page":"1437183","DOI":"10.3389\/fnut.2024.1437183","volume":"11","author":"YL Chen","year":"2024","unstructured":"Chen YL, Gao J, Wang XB, Lu H, Zheng Y, Ren Q. Serum folate levels and risk of metabolic dysfunction-associated steatotic liver disease: results from a cross-sectional study and Mendelian randomization analysis. Front Nutr. 2024;11:1437183.","journal-title":"Front Nutr"},{"key":"1805_CR15","doi-asserted-by":"publisher","first-page":"1366843","DOI":"10.3389\/fnut.2024.1366843","volume":"11","author":"JC Cai","year":"2024","unstructured":"Cai JC, Chen DH, Luo WJ, Xu F, Feng XF, Zhang LS, et al. The association between diverse serum folate with MAFLD and liver fibrosis based on NHANES 2017-2020. Front Nutr. 2024;11:1366843.","journal-title":"Front Nutr"},{"key":"1805_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jhep.2022.06.033","volume":"77","author":"M Tripathi","year":"2022","unstructured":"Tripathi M, Singh BK, Zhou J, Tikno K, Widjaja A, Sandireddy R, et al. Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation. J Hepatol. 2022;77:1246\u201355.","journal-title":"J Hepatol"},{"key":"1805_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3164\/jcbn.20-142","volume":"68","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi T, Kessoku T, Ozaki A, Iwaki M, Honda Y, Ogawa Y, et al. Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial. J Clin Biochem Nutr. 2021;68:181\u20136.","journal-title":"J Clin Biochem Nutr"},{"key":"1805_CR18","doi-asserted-by":"crossref","unstructured":"Wang K, Xiang SJ, He QS, Liu AR, Huang CM, Yang Z, et al. Mediterranean diet and associated metabolite signatures in relation to MASLD progression: A prospective cohort study. Hepatol Commun. 2025;9:e0791.","DOI":"10.1097\/HC9.0000000000000791"},{"key":"1805_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ajcnut.2024.08.027","volume":"120","author":"YS Wang","year":"2024","unstructured":"Wang YS, Mi NN, Liao K, Li Y, Sun YX, Xie P, et al. Associations among dietary 1-carbon metabolism nutrients, genetic risk, and Alzheimer disease: a prospective cohort study. Am J Clin Nutr. 2024;120:1009\u201318.","journal-title":"Am J Clin Nutr"},{"key":"1805_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-018-0571-7","volume":"562","author":"LT Elliott","year":"2018","unstructured":"Elliott LT, Sharp K, Alfaro-Almagro F, Shi S, Miller KL, Douaud G, et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature. 2018;562:210\u20136.","journal-title":"Nature"},{"key":"1805_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"1805_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"1805_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"key":"1805_CR24","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00394-021-02535-x","volume":"60","author":"C Piernas","year":"2021","unstructured":"Piernas C, Perez-Cornag A, Gao M, Young H, Pollard Z, Mulligan A, et al. Describing a new food group classification system for UK biobank: analysis of food groups and sources of macro- and micronutrients in 208,200 participants. Eur J Nutr. 2021;60:2879\u201390.","journal-title":"Eur J Nutr"},{"key":"1805_CR25","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00394-021-02558-4","volume":"60","author":"A Perez-Cornago","year":"2021","unstructured":"Perez-Cornago A, Pollard Z, Young H, van Uden M, Andrews C, Piernas C, et al. Description of the updated nutrition calculation of the Oxford WebQ questionnaire and comparison with the previous version among 207,144 participants in UK Biobank. Eur J Nutr. 2021;60:4019\u201330.","journal-title":"Eur J Nutr"},{"key":"1805_CR26","doi-asserted-by":"crossref","unstructured":"Kelly RK, Pollard Z, Young H, Piernas C, Lentjes M, Mulligan A, et al. Evaluation of the New Individual Fatty Acid Dataset for UK Biobank: Analysis of Intakes and Sources in 207,997 Participants. Nutrients. 2022;14:3603.","DOI":"10.3390\/nu14173603"},{"key":"1805_CR27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/HEP.0000000000000356","volume":"78","author":"L Calzadilla-Bertot","year":"2023","unstructured":"Calzadilla-Bertot L, Jeffrey GP, Wang ZY, Huang Y, Garas G, Wallace M, et al. Predicting liver-related events in NAFLD: a predictive model. Hepatology. 2023;78:1240\u201351.","journal-title":"Hepatology"},{"key":"1805_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1053\/j.gastro.2023.01.040","volume":"164","author":"VL Chen","year":"2023","unstructured":"Chen VL, Oliveri A, Miller MJ, Wijarnpreecha K, Du XM, Chen YH, et al. PNPLA3 genotype and diabetes identify patients with nonalcoholic fatty liver disease at high risk of incident cirrhosis. Gastroenterology. 2023;164:966\u201377.e17.","journal-title":"Gastroenterology"},{"key":"1805_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2337\/dc21-1512","volume":"45","author":"H Han","year":"2022","unstructured":"Han H, Cao YY, Feng CW, Zheng Y, Dhana K, Zhu S, et al. Association of a healthy lifestyle with all-cause and cause-specific mortality among individuals with type 2 diabetes: a prospective study in UK biobank. Diab Care. 2022;45:319\u201329.","journal-title":"Diab Care"},{"key":"1805_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cgh.2025.06.001","volume":"24","author":"Y Shi","year":"2026","unstructured":"Shi Y, Kim SU, Yip TCF, Tsochatzis E, Petta S, Nakajima A, et al. Effect of antidiabetic drug classes on the risk of liver-related events in individuals with T2D and MASLD. Clin Gastroenterol Hepatol. 2026;24:723\u201332.e10.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1805_CR31","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/jdi.14246","volume":"15","author":"D Ito","year":"2024","unstructured":"Ito D, Shimizu S, Haisa A, Yanagisaw S, Inoue K, Saito D, et al. Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: effect of ipragliflozin in MASLD. J Diab Investig. 2024;15:1220\u201330.","journal-title":"J Diab Investig"},{"key":"1805_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molmet.2014.04.010","volume":"3","author":"C Dahlhoff","year":"2014","unstructured":"Dahlhoff C, Worsch S, Sailer M, Hummel BA, Fiamoncini J, Uebel K, et al. Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Mol Metab. 2014;3:565\u201380.","journal-title":"Mol Metab"},{"key":"1805_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","volume":"57","author":"QM Anstee","year":"2012","unstructured":"Anstee QM, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J Hepatol. 2012;57:1097\u2013109.","journal-title":"J Hepatol"},{"key":"1805_CR34","unstructured":"Hardy ML, Coulter I, Morton SC, Favreau J, Venuturupalli S, Chiappelli F, et al. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Evid Rep Technol Assess (Summ). 2003:1\u20133."},{"key":"1805_CR35","doi-asserted-by":"publisher","first-page":"994","DOI":"10.14309\/ajg.0000000000001072","volume":"116","author":"E Vilar-Gomez","year":"2021","unstructured":"Vilar-Gomez E, Pirola CJ, Sookoian S, Wilson LA, Belt P, Liang T, et al. Impact of the association between PNPLA3 genetic variation and dietary intake on the risk of significant fibrosis in patients with NAFLD. Am J Gastroenterol. 2021;116:994\u20131006.","journal-title":"Am J Gastroenterol"},{"key":"1805_CR36","doi-asserted-by":"publisher","first-page":"1426103","DOI":"10.3389\/fendo.2024.1426103","volume":"15","author":"JX Zhu","year":"2024","unstructured":"Zhu JX, Liao XY, Du L, Lv PJ, Deng J. Associations of serum folate and vitamin B12 levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study. Front Endocrinol (Lausanne). 2024;15:1426103.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1805_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S000711452400285X","volume":"133","author":"H Ma","year":"2025","unstructured":"Ma H, Liu H, Yang YT, Han M, Jiang CM. The effect of folate deficiency and different doses of folic acid supplementation on liver diseases. Br J Nutr. 2025;133:37\u201347.","journal-title":"Br J Nutr"},{"key":"1805_CR38","first-page":"158","volume":"32","author":"B Zhang","year":"2023","unstructured":"Zhang B, Cao JC, Liu FR, Deng Z, Chen CJ, Sun YY. Folate intake and non-alcoholic fatty liver disease in US adults. Asia Pac J Clin Nutr. 2023;32:158\u201367.","journal-title":"Asia Pac J Clin Nutr"},{"key":"1805_CR39","doi-asserted-by":"crossref","unstructured":"Bo YC, Xu HD, Zhang HH, Zhang JX, Wan ZX, Zhao X, et al. Intakes of folate, Vitamin B6, and Vitamin B12 in relation to all-cause and cause-specific mortality: a national population-based cohort. Nutrients. 2022;14:2253.","DOI":"10.3390\/nu14112253"},{"key":"1805_CR40","doi-asserted-by":"crossref","unstructured":"Roswall N, Olsen A, Christensen J, Hansen L, Dragsted LO, Overvad K, et al. Micronutrient intake in relation to all-cause mortality in a prospective Danish cohort. Food Nutr Res. 2012;56:5466.","DOI":"10.3402\/fnr.v56i0.5466"},{"key":"1805_CR41","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1001\/jama.2009.1622","volume":"302","author":"M Ebbing","year":"2009","unstructured":"Ebbing M, B\u00f8naa KH, Nyg\u00e5rd O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302:2119\u201326.","journal-title":"JAMA"},{"key":"1805_CR42","doi-asserted-by":"publisher","first-page":"1015046","DOI":"10.3389\/fnut.2023.1015046","volume":"10","author":"LW Fu","year":"2023","unstructured":"Fu LW, Wang YQ, Hu YQ. Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data. Front Nutr. 2023;10:1015046.","journal-title":"Front Nutr"},{"key":"1805_CR43","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.bbamem.2013.10.018","volume":"1838","author":"DE Vance","year":"2014","unstructured":"Vance DE. Phospholipid methylation in mammals: from biochemistry to physiological function. Biochim Biophys Acta. 2014;1838:1477\u201387.","journal-title":"Biochim Biophys Acta"},{"key":"1805_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1684\/ecn.2019.0437","volume":"30","author":"S Youssry","year":"2019","unstructured":"Youssry S, Kamel MA. Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver disease. Eur Cytokine Netw. 2019;30:135\u201343.","journal-title":"Eur Cytokine Netw"},{"key":"1805_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/biof.1154","volume":"40","author":"RP da Silva","year":"2014","unstructured":"da Silva RP, Kelly KB, Rajabi AA, Jacobs RL. Novel insights on interactions between folate and lipid metabolism. Biofactors. 2014;40:277\u201383.","journal-title":"Biofactors"},{"key":"1805_CR46","doi-asserted-by":"publisher","first-page":"35785","DOI":"10.1074\/jbc.M602799200","volume":"281","author":"V Vitvitsky","year":"2006","unstructured":"Vitvitsky V, Thomas M, Ghorpade A, Gendelman HE, Banerjee R. A functional transsulfuration pathway in the brain links to glutathione homeostasis. J Biol Chem. 2006;281:35785\u201393.","journal-title":"J Biol Chem"},{"key":"1805_CR47","doi-asserted-by":"publisher","first-page":"1344924","DOI":"10.3389\/fnut.2024.1344924","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y, Qin X, Chen TZ, Chen MY, Wu LY, He BH. Exploring the interactions between metabolic dysfunction-associated fatty liver disease and micronutrients: from molecular mechanisms to clinical applications. Front Nutr. 2024;11:1344924.","journal-title":"Front Nutr"},{"key":"1805_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206068","volume":"10","author":"SR Wang","year":"2023","unstructured":"Wang SR, Zha L, Cui X, Yeh YT, Liu RC, Jing J, et al. Epigenetic regulation of hepatic lipid metabolism by DNA methylation. Adv Sci (Weinh). 2023;10:e2206068.","journal-title":"Adv Sci (Weinh)"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01805-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:26:02Z","timestamp":1788467162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":48,"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1038\/s41430-026-01805-3","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Ethical approval for this study was obtained from the UK National Health Service\u2019s National Research Ethics Service (REC reference: 16\/NW\/0274), and the study was conducted under UK Biobank application number 51671. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}